Plegamiento defectuoso de proteínas y enfermedad - GIC 21/069
![Foto de Plegamiento defectuoso de proteínas y enfermedad - GIC 21/069](/img/grupo.png)
![Foto de AstraZeneca (United Kingdom)](/img/noimage_org.png)
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublications in collaboration with researchers from AstraZeneca (United Kingdom) (1)
2014
-
Iridium-catalyzed C-H borylation of pyridines
Organic and Biomolecular Chemistry, Vol. 12, Núm. 37, pp. 7318-7327